FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

L. Perrigo Scopolamine Transdermal Therapeutic System Recall

Scopolamine Transdermal Therapeutic System, 1 mg/3 days, a) 4-count (NDC 45802-580-84)

L. Perrigo Company · Allegan, MI

Risk level
Class II
Reported by FDA
May 23, 2018
Recall ID
D-0816-2018
Check your lot numberHow we source this data

Summary

L. Perrigo recalled Scopolamine Transdermal Therapeutic System starting May 11, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0816-2018 on May 23, 2018. Reason: Defective delivery system. Status: Terminated.

Why it was recalled

Defective delivery system

Product description

Scopolamine Transdermal Therapeutic System, 1 mg/3 days, a) 4-count (NDC 45802-580-84); b) 10-count (NDC 45802-580-46); c) 24-count (NDC 45802-580-62), Rx only, Mfd. by: Aveva Drug Delivery Systems, A Nitto Denko Company, Miramar, FL 33025 Distributed by Perrigo, Allegan, MI 49010

Lot numbers, UPCs & expiration codes

Lot #: a) 46397, 46457 Exp 03/19; 46621, Exp 04/19; 46894, 46904, 46905, Exp 06/19; 47133, Exp 07/19; 47153, Exp 08/19; 47154, 47213, 47214, Exp 09/19; b) 46695, Exp 04/19; 46994, 47012, Exp 07/19; 47322 10/19; c) 46822, Exp 05/19 ; 47155, 47212, Exp 09/19

Where it was sold

Nationwide in the U.S.A.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0816-2018
Classification
Class II
Status
Terminated
Recall initiated
May 11, 2018
FDA report date
May 23, 2018
Quantity
569,520 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
L. Perrigo Company

Original FDA data

Every field from FDA enforcement report D-0816-2018, exactly as published.

Show all FDA fields
City
Allegan
State
MI
Status
Terminated
Country
United States
Event ID
80041
Address
515 Eastern Ave
Code information
Lot #: a) 46397, 46457 Exp 03/19; 46621, Exp 04/19; 46894, 46904, 46905, Exp 06/19; 47133, Exp 07/19; 47153, Exp 08/19; 47154, 47213, 47214, Exp 09/19; b) 46695, Exp 04/19; 46994, 47012, Exp 07/19; 47322 10/19; c) 46822, Exp 05/19 ; 47155, 47212, Exp 09/19
Postal code
49010-9070
Report date
May 23, 2018
Product type
Drugs
Recall number
D-0816-2018
Classification
Class II
Recalling firm
L. Perrigo Company
Product quantity
569,520 cartons
Termination date
Sep 28, 2020
Reason for recall
Defective delivery system
Voluntary / mandated
Voluntary: Firm initiated
Product description
Scopolamine Transdermal Therapeutic System, 1 mg/3 days, a) 4-count (NDC 45802-580-84); b) 10-count (NDC 45802-580-46); c) 24-count (NDC 45802-580-62), Rx only, Mfd. by: Aveva Drug Delivery Systems, A Nitto Denko Company, Miramar, FL 33025 Distributed by Perrigo, Allegan, MI 49010
Distribution pattern
Nationwide in the U.S.A.
Recall initiation date
May 11, 2018
Initial firm notification
Letter
Center classification date
May 15, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0816-2018, published May 23, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls